Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAFV600E mutation bearing metastatic melanoma cells

Evan L. Carpenter, Sharmeen Chagani, Dylan Nelson, Pamela B. Cassidy, Madeleine Laws, Gitali Ganguli-Indra, Arup K. Indra

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF<sup>V600E</sup> mutation bearing metastatic melanoma cells'. Together they form a unique fingerprint.

Medicine & Life Sciences